Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Following the collapse of its Joint Venture arrangement...
Reflecting the worldwide stock market slide, the...
WuXi PharmaTech has signed a new three-year CRO deal with...
Charles River Labs noted a slowdown in the worldwide CRO...
WuXi PharmaTech (药明康德) announced it will...
An AIDS vaccine, developed by China scientists, produced...
The 4th ChinaBio® Investor Forum showed China...
WuXi PharmaTech (药明康德) met, but didn’t...
Seventeen early to mid-stage companies from the Pearl...
Eli Lilly and Company will not attempt a large-scale...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
